News

Innovation board promises $100,000 grant for rural regions

Rural Southwest and Southside Virginia are in line for a new six-figure grant for entrepreneurship, the Virginia Innovation Partnership Corporation has announced.

The innovation partnership, which held its board meeting Wednesday at the New College Institute in Martinsville, gave word at a Tuesday night dinner that it will commit $100,000. That’s the latest grant in a series that the partnership has given in the region over the past couple of years.

Details on how to access the funding were not available yet but are forthcoming, VIPC spokeswoman Angela Costello said.

“That funding is going to be part of collaborating and partnering to help foster more ecosystem growth, around entrepreneurship, around startups,” said Joe Benevento, VIPC’s interim president and CEO. “And that involves really key aspects such as mentorship, for example, so that we can understand where the gaps and challenges are, that we can help solve for in rural Virginia, and particularly in this region.”

The work force is here, and capable, he said. But Benevento wants to help grow the investment capital side of the equation, particularly in the early stages, through the likes of angel investors.

“And I think it’s an area that, through partnerships and collaborations with other stakeholders here locally, would really help take the ecosystem to that next level,” he said.

Virginia Secretary of Commerce and Trade Caren Merrick is the VIPC vice chair.

Merrick said that committing $100,000 is “a great idea, because it grabs people’s attention. And it says we’re not just talking about [it], and we’re actually going to do something about it. And we will be providing more guidance on that in the not-too-distant future.”

Merrick and Benevento said the grant is intended for the GO Virginia economic initiative’s regions 1, 2 and 3, which cover most of Southwest and Southside.

The Virginia Innovation Partnership Corporation has developed multiple sponsorships in the three regions over the past couple of years, according to information that Costello provided. Those include:

  • $45,000 in VIPC Virginia Accelerator Network sponsorships for fiscal year 2023-24 to the Launch Place, a venture development organization that works in areas including Martinsville, Danville and Pittsylvania County.
  • $25,000 for the Advancement Foundation, which works with entrepreneurs in Southside and Southwest Virginia and the Shenandoah Valley.
  • $7,500 annually for the Southern Piedmont Technology Council, Southside’s regional technology council.

The corporation also has co-hosted Global Entrepreneurship Week virtual meetup events in 2022 and 2023 with the SOVA Innovation Hub and Longwood University, and its staff participates regularly in Southern Virginia Regional Investment in Startups & Entrepreneurs, a regional initiative for entrepreneurship and innovation in Southern Virginia.

For the GO Virginia regions in question, $100,000 is “a starting point,” Benevento said.

“What hopefully it signals is that we want to help be a catalyst to leverage and amplify and activate greater capital through public and private partnerships,” he said. “So I think it … will help catalyze that conversation and get some of the right people and the right stakeholders in the room together and at the table, and see where it goes from there.”

Recent News

05/22/2026

BIO Statement on Veto of Prescription Drug Affordability Boards (PDAB) in VirginiaPatrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB) legislation in Virginia: “BIO applauds Governor Spanberger’s decision to veto SB 271 and HB 483 — legislation that would have established a Prescription Drug Affordability Board (PDAB) and imposed arbitrary price controls in Virginia. The Governor’s action recognized an important point: even well-intentioned healthcare policies must be carefully designed to avoid unintended consequences for patients, providers, employers, and Virginia’s innovation economy. “BIO is proud to represent biotechnology companies developing the next generation of life-changing medicines, including many in the Commonwealth. We believe policymakers play a critically important role in helping advance both patient access to treatments and the continued growth of the life sciences sector. “We look forward to working with the Governor’s Administration, the General Assembly, Virginia Bio and other stakeholders to advance practical, patient-centered policy solutions that improve affordability while preserving access to care and the innovation ecosystem patients depend on.”

Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB) legislation in Virginia: “BIO applauds Governor Spanberger’s decision to veto SB 271 and HB 483 — legislation that would have established a Prescription

05/21/2026

Virginia Bio Applauds Governor Spanberger’s Veto of SB 271 and HB 483

The Virginia Biotechnology Association (Virginia Bio) today expressed strong support for Governor Abigail Spanberger’s decision to veto Senate Bill 271 and House Bill 483, legislation that would have established a Prescription Drug Affordability Advisory Panel (PDAAP) in the Commonwealth. Virginia Bio and the Virginia Chamber of Commerce sent a joint letter to Governor Spanberger commending

05/21/2026

New Global Clinical Society to Bring Focused Ultrasound Into Mainstream Medicine

The Focused Ultrasound Foundation today announced the launch of the International Focused Ultrasound Society (IFUS), a new organization dedicated to advancing clinical practice and accelerating adoption of focused ultrasound – a revolutionary, noninvasive therapeutic technology. Established as a program of the Focused Ultrasound Foundation, IFUS aggregates and expands the Foundation’s activities related to clinical implementation